Replies to post #100915 on Biotech Values

[DFRAI]

Dewdiligence
did anyone add up the lovenox costs owed to Novartis - Craig stated that they would payback all in 3 quarters. furthermore only 50% of royalty would go towards recovering those costs with remaining 50% would be recognized as sales/profit by MNTA.

Without doing any calculations - i would have to guess that MNTA will earn much more than 50 million per year according to Craig's thinking that they will pay back debt to novartis in 3 quarters - what is your thinking?

[RockRat]

Does anyone else have a hard time believing the FDA would set itself up for a second count of arbitrary and capricious behavior by approving Teva's ANDA before the lawsuit for SNY is resolved? I personally don't think it would, and that's the main reason I don't buy the Bernstein analyst's assertion that tEnoxaparin will be approved any time soon, aside from the fact that it looks parroted from Teva's statements on the matter. But I'm no lawyer. I don't even play one on television.

IJ has already said elsewhere he has no idea, but I was wondering what the other folks with legal expertise thought about this.

Regards, RockRat